RIGL
RigelDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The best post-earnings bull read is that Q1 still showed 26% year-over-year net product sales growth, another profitable quarter, $146.7 million of cash and short-term investments at March 31, 2026, and reaffirmed 2026 revenue guidance despite the Lilly reset, which supports a monitoring-style constructive view rather than a broken thesis [#8-K-2026-05-05] [#10-Q-2026-05-05].
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.1.
What can break
Commercial products still face the usual biotech risks around demand variability, competition, pricing, reimbursement, and regulatory decisions noted in the company’s forward-looking disclosures [#8-K-2026-05-05].
Momentum
28
Value
71
Sentiment
44
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $28.00 · Bull $40.00 · Bear $18.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $51.60
Why
Momentum28 · Δ7d +1.3
Value71 · Δ7d +0.1
Sentiment44 · Δ7d +0.1
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
28
34% active weight
Current posture
7d trendFlat
Δ7d
+1.3
Δ21d
+15.5
Value
71
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.3
Sentiment
44
33% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-5.6
Why this grade
Composite grade D. Momentum 28.4 / Value 70.8 / Sentiment 43.6
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$555.43M
Beta
1.11
Shares Out
18.15M
P/E (TTM)
6.7
P/S (TTM)
2.65
P/FCF (TTM)
10.97
Rev YoY
+25.6%
EPS YoY
+106.9%
Gross Margin
+93.1%
Op Margin
+42.2%
Net Debt
-$17.64M
Current Ratio
2.28
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology